An Open-label, Multi-center Study to Evaluate the Efficacy and Safety of Statin-fenofibrate Combination Therapy in Dyslipidemic Chinese Patients.
Phase of Trial: Phase IV
Latest Information Update: 24 Mar 2015
At a glance
- Drugs Fenofibrate (Primary)
- Indications Hypertriglyceridaemia
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 10 Jun 2017 Biomarkers information updated
- 09 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 10 Jan 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.